Une contribution à la lutte mondiale contre le paludisme

Un enfant est assis dans un hamac, protégé par une moustiquaire.
Enfant placé sous une moustiquaire pour le protéger des piqûres de moustiques, source de transmission du paludisme. © Swiss Malaria Group / Elder Figuera

Malgré des progrès constants dans la maîtrise de la maladie, le paludisme reste encore l’un des principaux fléaux dans de nombreux pays, notamment en Afrique subsaharienne. Dans sa lutte contre les conséquences sanitaires et économiques qui accablent ses pays partenaires, la DDC met l’accent d’une part sur la prévention et d’autre part sur l’accès aux soins.

En point de mire de la DDC

La Suisse jouit d’une reconnaissance mondiale dans le domaine de la recherche et de la mise en place de mesures innovantes pour prévenir et maîtriser le paludisme. La DDC a donc la chance de pouvoir collaborer avec de nombreux partenaires publics et privés reconnus pour leurs connaissances et leur expertise dans le domaine du paludisme.

La DDC contribue à la lutte antipaludique grâce à des partenariats bilatéraux et multilatéraux. Dans les pays où le paludisme est endémique, elle soutient des projets dont l’objectif est la distribution de moustiquaires, le renforcement des systèmes sanitaires et le soutien aux initiatives des communautés locales. Au niveau international, la DDC fournit des contributions financières à des initiatives mondiales telles que le Fonds mondial de lutte contre le SIDA, la tuberculose et le paludisme, à des institutions académiques reconnues internationalement ainsi qu’à des partenariats public-privé qui mènent des recherches pionnières et développent des moyens de prévention, des traitements et des outils diagnostics.

Sensibilisation et prise de conscience

La DDC est aussi à la tête du Swiss Malaria Group (SMG). Fondé en 2007, celui-ci comprend onze membres issus des secteurs public et privé ainsi que de la société civile. L’objectif du SMG consiste à sensibiliser les décideurs et le public au problème du paludisme et à ses conséquences, tout en encourageant la Suisse à soutenir les organisations actives dans la lutte contre cette maladie. Les membres du groupe s’allient pour réduire le nombre de cas de paludisme dans les pays les plus touchés, grâce à des mesures de contrôle innovantes et au partage des connaissances et des ressources financières.

Contexte

De nombreux pays ont réalisé des progrès considérables dans la maîtrise du paludisme, réduisant non seulement le taux de mortalité infantile mais aussi le nombre d’infections. Ces résultats sont dus à une meilleure coordination des différents acteurs à l’échelle mondiale, à des investissements massifs dans la lutte antipaludique et à la mise à disposition d’outils efficaces pour la prévention, le diagnostic et le traitement. Toutefois, le développement de résistances aux médicaments et aux insecticides est un obstacle majeur à la pérennisation de ces acquis.

Projets actuels

Objet 1 – 10 de 10

  • 1

Swiss Malaria Group

01.01.2024 - 31.12.2025

Founded in 2007 as an informal network, the Swiss Malaria Group (SMG) has undergone organisational development leading to a formalized multi-stakeholder group with a strategic focus on raising awareness about malaria and the comparative advantage of Switzerland to defeat the disease. Organised as an association, with an Executive Secretariat hosted by Medicus Mundi Switzerland, the 15 organisations help accelerating malaria elimination, through innovative control measures, knowledge and financial flows.


Innovative Vector Control Consortium (IVCC)

01.08.2020 - 31.07.2024

Vector-borne neglected tropical diseases (NTDs) and malaria are major causes of mortality, morbidity and lack of economic progress for the poorest. Targeting the vector (mosquito) is a main eradication approach. Due to climate change and natural mutation, insecticide resistance is affecting most malaria endemic countries. The Innovative Vector Control Consortium (IVCC) is the world-leader Product Development Partnership developing innovative and safe insecticides. SDC strategic support to IVCC complements Switzerland’s global action against malaria. 


Contribution to the Global Fund to Fight AIDS, Tuberculosis and Malaria (GF)

01.01.2020 - 31.12.2022

Health is a precondition, an indicator and a result of sustainable development. The Global Fund (GF) follows the vision of a world free of HIV/AIDS, tuberculosis and malaria. It collects and channels a big share of the international funds dedicated to end these epidemics that disproportionately affect the poorest and most vulnerable people. Its support to country programmes has saved 27 million lives since 2002. In the coming years, the challenge is to maintain this progress and step up the fight to ending the epidemics. 


Swiss Malaria Group (SMG)

01.01.2020 - 31.12.2023

The Swiss Malaria Group (SMG) gathers all Swiss-based institutions active nationally and internationally in the fight against malaria. The 16 members’ organizations from the public, private, academic and non-for-profit sectors coordinate their efforts in order to engaging Swiss technical expertise, opinion makers and the general public to provide Swiss leadership against malaria at global and national levels, strengthen research and innovation by Swiss actors and fight malaria on the ground in all affected settings.


BACKUP Health Technical support for Global Fund country partners

01.12.2019 - 31.08.2023

Switzerland supports The Global Fund to fight AIDS, Tuberculosis and Malaria with 64 million CHF for three years (2020-2022). As the Fund is a global financing mechanism without country presence that provides grants to recipient countries. The BACKUP Health initiative strives to strengthen governments and other national stakeholders in such way that they embed Global Fund grant proposals in broader health sector priorities.


Global Malaria Technical & Training Support Package (GlobMal)

01.07.2019 - 30.06.2023

The worldwide reduction in malaria-related death in the last two decades is a major global public health success. Despite the 6 million lives saved from malaria, still more than 400’000 people die every year. The project aims to shape effective global and national malaria control and elimination strategies, by providing the necessary scientific evidence and strengthening capacities of malaria-affected countries. Swiss research and private sector contribute to the design and implementation of these global and national malaria strategies.


BACKUP Health: Technical support for Global Fund country partners

01.01.2019 - 31.12.2022

The Global Fund aims at ending AIDS, Tuberculosis, and Malaria as epidemics. It works with country-based partners. The coordination mechanism through which these partners operate often requires technical assistance. SDC’s support to BACKUP Health is meant to improve the effectiveness of the coordinating mechanisms in order to ensure that the activities supported by the Global Fund  benefit the poor and vulnerable populations. Experiences gathered by the BACKUP Health in countries will be used to influence strategic decisions at Board level.


Towards Elimination of Malaria in Tanzania

NETCELL project, 2017

01.12.2018 - 30.04.2024

Tanzania deploys innovative approaches for malaria control and elimination since 2000. To sustain and expand gains that have been achieved, the project will capacitate Tanzanian institutions to engage in subnational, intersectoral and cross borders elimination strategies, thus making available best practices to normative bodies such as World Health Organization (WHO). Tanzania’s and Switzerland’s recognized strong expertise, network and influence in malaria elimination will be increased through this programme.


BACKUP Health Technical support for Global Fund country partners

01.07.2017 - 31.03.2020

Based in Geneva, the Global Fund to fight AIDS, Tuberculosis, and Malaria does not have representations in the countries receiving its grants. To foster effective the implementation of its support, the Global Fund relies on coordination mechanisms that gather the main country-based partners, including people affected by the diseases. SDC co-financing of the BACKUP Health initiative aims at strengthening this multi-stakeholder management of Global Fund grants, reinforce accountability and increase the impact of the Global Fund.


Medicines for Malaria Venture (MMV)

01.01.2017 - 31.12.2021

To contest the increasing problem of drug resistance and to accelerate malaria elimination, new drugs against malaria are needed. The Geneva-based Medicines for Malaria Venture (MMV) drives the discovery, development and implementation of new antimalarial drugs. Working with pharmaceutical, academic and affected country partners, MMV reduces costs and ensures affordable and equitable access to quality medicines by vulnerable groups at risk of malaria, in particular children and pregnant women.

Objet 1 – 10 de 10

  • 1